跳至主要内容
临床试验/EUCTR2009-010381-30-NL
EUCTR2009-010381-30-NL进行中(未招募)不适用

Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia. - Salbutamol for developing BPD

Isala klinieken0 个研究点开始时间: 2009年6月3日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Preterm infants (< 35 wk PMA) who receive ventilatory support and oxygen therapy > 21% and clinically suspected of developing BPD.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Neonates with ‘major’ congenital malformations, neonates with a life expectancy of less than 72 hours, neonates who receive potassium supplementation.

研究者

发起方
Isala klinieken

相似试验